TG Therapeutics (TGTX) total debt

Total debt · fiscal 2025
$253.71M

TG Therapeutics (TGTX) carried total debt of $253.71M at the end of fiscal 2025 (December 31, 2025). That is level with fiscal 2024. Figures as of 18 Nov 2026, 09:47 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$253.71M
Change on fiscal 2024
−0.0%
Growth, 5 years
+53.4% a year
Highest on record
$253.72Mfiscal 2024
Lowest on record
$0.00fiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

TG Therapeutics total debt, in more detail

Over the five fiscal years to 2025 total debt grew at a compound 53.4% a year. Across the 8 fiscal years on record (2018–2025), the highest was $253.72M in fiscal 2024 and the lowest $0.00 in fiscal 2018.

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

History · 8 fiscal years

Total debt by fiscal year

TG Therapeutics total debt, year by year

TG Therapeutics (TGTX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$253.71M 0.0% down0.4×
2024$253.72M 129.0% up1.1×
2023$110.80M 33.4% up0.7×
2022$83.06M 22.6% up1.4×
2021$67.76M 126.7% up0.3×
2020$29.90M 3.2% up0.1×
2019$28.97M—0.8×
2018$0.00—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of TG Therapeutics and comparable companies
CompanyTotal debtFiscal year
Madrigal Pharmaceuticals MDGL$347.63M2025
Henry Schein HSIC$3.44B2025
Oscar Health OSCR$430.10M2025
TG Therapeutics TGTX$253.71M2025
Praxis Precision Medicines PRAX$110.00K2025
Twist Bioscience TWST$94.99M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TGTX

TG Therapeutics, figure by figure

TG Therapeutics (TGTX) overview: price, valuation and scorecardAll health care companies by market value

TG Therapeutics total debt: questions and answers

How much debt does TG Therapeutics have?

TG Therapeutics (TGTX) carried total debt of $253.71M at the end of fiscal 2025 (December 31, 2025). That is level with fiscal 2024.

What is the growth rate of TG Therapeutics's total debt?

Over the five fiscal years to 2025 total debt grew at a compound 53.4% a year.

What are the highest and lowest total debt figures on record for TG Therapeutics?

Across the 8 fiscal years on record (2018–2025), the highest was $253.72M in fiscal 2024 and the lowest $0.00 in fiscal 2018.

How does TG Therapeutics's debt compare with its equity?

Total debt was 0.4× shareholders' equity at the end of fiscal 2025.

How is TG Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For TG Therapeutics it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “TG Therapeutics (TGTX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/TGTX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.